Drug Manufacturers - Specialty & Generic | Healthcare
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 amino 1 adamantanol, N boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.
Market Cap
16799154176
Current Price
530.35
52 Week Range
305.5 - 745.0
Previous Close
529.85
Open
530.4
Sector
Healthcare
Address
602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39 A/1 Road No. 23, Wagle Industrial Estate Thane (West), Thane, 400604, India
Phone
+91-22661-77400
Fax
+91-22661-77458
Website
https://www.bajajhealth.com
Day Low
530.4
Day High
536.15
Dividend Yield
0.19
PE Ratio
37.34859
Earnings Per Share
14.2
Beta
0.257
EBITDA
824254976
Book Value
147.634
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Sajankumar Rameshwarlal Bajaj | Founder, Chairman & MD | 64 | 1960 |
Mr. Anil Champalal Jain | Vice Chairman & Joint MD | 49 | 1975 |
Ms. Namrata Sajankumar Bajaj | Whole Time Director | 38 | 1986 |
Mr. Dhananjay Sabaji Hatle | Whole-Time Director | 52 | 1972 |
Mr. Pakshal Anil Jain | Whole Time Director | 26 | 1998 |
Mr. Nandkumar R. Soni | Senior Vice President of Operations and Unit II Head- Salvi | - | - |
Mr. Amit Rajan M.Tech | Chief Technical Officer | - | - |
Ms. Monica Tanwar | Company Secretary & Compliance Officer | - | - |
Mr. A.G. Prasad | Executive Vice President Sales & Marketing | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.